Annual Gross Profit
$135.27 M
+$47.66 M+54.39%
31 December 2023
Summary:
Xeris Biopharma Holdings annual gross profit is currently $135.27 million, with the most recent change of +$47.66 million (+54.39%) on 31 December 2023. During the last 3 years, it has risen by +$124.16 million (+1117.87%). XERS annual gross profit is now at all-time high.XERS Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$40.67 M
+$400.00 K+0.99%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly gross profit is currently $40.67 million, with the most recent change of +$400.00 thousand (+0.99%) on 30 September 2024. Over the past year, it has increased by +$556.00 thousand (+1.39%). XERS quarterly gross profit is now at all-time high.XERS Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$152.44 M
+$556.00 K+0.37%
30 September 2024
Summary:
Xeris Biopharma Holdings TTM gross profit is currently $152.44 million, with the most recent change of +$556.00 thousand (+0.37%) on 30 September 2024. Over the past year, it has increased by +$27.14 million (+21.66%). XERS TTM gross profit is now at all-time high.XERS TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.4% | +1.4% | +21.7% |
| 3 y3 years | +1117.9% | +418.8% | +543.4% |
| 5 y5 years | +5482.7% | +10000.0% | +9088.5% |
XERS Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1117.9% | at high | +418.8% | at high | +543.4% |
| 5 y | 5 years | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Xeris Biopharma Holdings Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $40.67 M(+1.0%) | $152.44 M(+0.4%) |
| June 2024 | - | $40.27 M(+16.2%) | $151.88 M(+6.9%) |
| Mar 2024 | - | $34.67 M(-5.8%) | $142.06 M(+5.0%) |
| Dec 2023 | $135.27 M(+54.4%) | $36.82 M(-8.2%) | $135.27 M(+8.0%) |
| Sept 2023 | - | $40.12 M(+31.7%) | $125.30 M(+14.3%) |
| June 2023 | - | $30.45 M(+9.2%) | $109.65 M(+10.0%) |
| Mar 2023 | - | $27.88 M(+3.8%) | $99.69 M(+13.8%) |
| Dec 2022 | $87.61 M(+141.5%) | $26.85 M(+9.8%) | $87.61 M(+13.3%) |
| Sept 2022 | - | $24.46 M(+19.4%) | $77.30 M(+27.4%) |
| June 2022 | - | $20.50 M(+29.7%) | $60.68 M(+32.8%) |
| Mar 2022 | - | $15.80 M(-4.5%) | $45.70 M(+26.0%) |
| Dec 2021 | $36.27 M(+226.6%) | $16.54 M(+111.0%) | $36.27 M(+53.1%) |
| Sept 2021 | - | $7.84 M(+42.0%) | $23.69 M(+5.7%) |
| June 2021 | - | $5.52 M(-13.3%) | $22.43 M(+27.2%) |
| Mar 2021 | - | $6.37 M(+60.8%) | $17.63 M(+58.2%) |
| Dec 2020 | $11.11 M | $3.96 M(-39.7%) | $11.15 M(+49.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $6.57 M(+802.7%) | $7.45 M(+526.9%) |
| June 2020 | - | $728.00 K(-738.6%) | $1.19 M(+56.9%) |
| Mar 2020 | - | -$114.00 K(-143.7%) | $757.00 K(-32.4%) |
| Dec 2019 | $1.12 M(-53.8%) | $261.00 K(-16.6%) | $1.12 M(-32.5%) |
| Sept 2019 | - | $313.00 K(+5.4%) | $1.66 M(-14.0%) |
| June 2019 | - | $297.00 K(+19.8%) | $1.93 M(-21.3%) |
| Mar 2019 | - | $248.00 K(-69.0%) | $2.45 M(+1.1%) |
| Dec 2018 | $2.42 M(+56.1%) | $801.00 K(+37.6%) | $2.42 M(+16.0%) |
| Sept 2018 | - | $582.00 K(-28.9%) | $2.09 M(+24.6%) |
| June 2018 | - | $819.00 K(+270.6%) | $1.68 M(+18.2%) |
| Mar 2018 | - | $221.00 K(-52.7%) | $1.42 M(-8.6%) |
| Dec 2017 | $1.55 M(+45.5%) | $467.00 K(+174.7%) | $1.55 M(+43.0%) |
| Sept 2017 | - | $170.00 K(-69.7%) | $1.08 M(+18.6%) |
| June 2017 | - | $561.00 K(+58.5%) | $915.00 K(+158.5%) |
| Mar 2017 | - | $354.00 K | $354.00 K |
| Dec 2016 | $1.07 M | - | - |
FAQ
- What is Xeris Biopharma Holdings annual gross profit?
- What is the all time high annual gross profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual gross profit year-on-year change?
- What is Xeris Biopharma Holdings quarterly gross profit?
- What is the all time high quarterly gross profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly gross profit year-on-year change?
- What is Xeris Biopharma Holdings TTM gross profit?
- What is the all time high TTM gross profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM gross profit year-on-year change?
What is Xeris Biopharma Holdings annual gross profit?
The current annual gross profit of XERS is $135.27 M
What is the all time high annual gross profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual gross profit is $135.27 M
What is Xeris Biopharma Holdings annual gross profit year-on-year change?
Over the past year, XERS annual gross profit has changed by +$47.66 M (+54.39%)
What is Xeris Biopharma Holdings quarterly gross profit?
The current quarterly gross profit of XERS is $40.67 M
What is the all time high quarterly gross profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly gross profit is $40.67 M
What is Xeris Biopharma Holdings quarterly gross profit year-on-year change?
Over the past year, XERS quarterly gross profit has changed by +$556.00 K (+1.39%)
What is Xeris Biopharma Holdings TTM gross profit?
The current TTM gross profit of XERS is $152.44 M
What is the all time high TTM gross profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM gross profit is $152.44 M
What is Xeris Biopharma Holdings TTM gross profit year-on-year change?
Over the past year, XERS TTM gross profit has changed by +$27.14 M (+21.66%)